RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma

Clinical trial NCT07445022 · RECRUITING

Trial details

NCT number: NCT07445022
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Melanoma Advanced

Start date: 2026-01-28
Primary completion: 2028-09-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.